RESAAS Announces First-to-Market Online Ordering & Home Delivery of COVID-19 Rapid Tests

RESAAS Announces First-to-Market Online Ordering & Home Delivery of COVID-19 Rapid Tests

  • On November 12, 2020

VANCOUVER, B.C. (November 12, 2020) – RESAAS Services Inc. (TSX-V: RSS, OTCQB: RSASF), a technology platform for the real estate industry, is pleased to announce it has launched online ordering of COVID-19 Rapid Tests.

  • Instant online ordering available to RESAAS agents located in the United States.
  • Next-day express shipping available.
  • Tests are priced between $55 and $65 each, depending on volume.
  • Available in quantities of 6, 12 and 24 packs.
  • The Rapid Tests are authorized by the FDA, and present results in 8 minutes.
  • Also concludes if the antibody is present.
  • Easy-to-read finger-prick tests proven to be 98% accurate.

“RESAAS is committed to enabling our agents to return to real estate responsibly. We are proud to launch our online ordering service, allowing RESAAS agents located in the United States of America to order COVID-19 Rapid Tests direct to their offices or homes,” said RESAAS CEO, Tom Rossiter. “RESAAS has worked diligently with attorneys, and with guidance from the FDA, to enable a first-to-market direct-to-customer solution for purchasing COVID-19 Rapid Tests.”

###

The Company is not making any express or implied claims that its product has the ability to eliminate, cure or contain the COVID-19 (or SARS-2 Coronavirus) at this time.

At present, the FDA requires all Rapid Test kits be used in licensed clinical laboratories by prescription of a licensed health care provider. Upon receiving the Rapid Test kit, we recommend contacting your local test center to schedule an appointment.

0 Comments